保定市哪里有算生辰八字的-【火明耀】,推荐,海口哪里有算命比较准的,阿拉尔哪有算命的,运城哪里算命很准,广安有算命特别准的地方吗,南京算命谁算的好,太康有算卦准的地方吗
保定市哪里有算生辰八字的龙里哪里有算命比较准的人,东莞哪里算命靠谱,华池哪里有算命准的,宝鸡哪里有算命准的哪个地方算命比较准,商丘哪里算命算卦特别准比较灵,地方在哪个?,临沧哪有算命的大仙,光山哪里有算命比较准的人
After targeting keto and paleo dieters, Chipotle is courting vegetarians.The fast casual chain on Monday expanded its new line of diet-based bowls to include vegan and vegetarian options. "Lifestyle bowls" launched earlier this year with Whole30 and double protein meals in addition to the keto and paleo bowls.The lifestyle bowls are a way for Chipotle to market itself to a wide variety of customers focused on health, especially as it rebounds from E. coli and norovirus scares from a few years ago. And the vegetarian and vegan options could help raise awareness among an increasingly important customer base.Chipotle first introduced its vegan protein option, Sofritas, in 2014. Demand for Sofritas has continued to grow, the company said. Last year, it cooked 7.5 million pounds of Sofritas. Vegetarian and vegan meals made up roughly 12% of all the meals Chipotle sold in 2018."We've found that many people are increasingly looking for plant-based protein options," said Chris Brandt, Chipotle's chief marketing officer. The bowls don't include new vegan or vegetarian ingredients. They're only available as pre-configured options on Chipotle's website or mobile app.Taco Bell recently tried a similar tactic.In January, Taco Bell announced a plan to test out a vegetarian menu board that would highlight the restaurant's current vegetarian options, including tacos, tostadas burritos and crunchwraps. Putting all of the meat-free items on one menu should make it easier for vegetarians to see their options, Taco Bell explained. For Chipotle, the lifestyle bowls are a way not only to lure vegetarian eaters, but to create positive hype for the brand.During an earnings call in February, CEO Brian Niccol said that the lifestyle bowls "resonated with consumers in a big way." CFO John Hartung said the bowls "created an awful lot of buzz and interest.""The whole idea here is to really emphasize again that Chipotle can be an option for virtually any diet," said Sharon Zackfia, an analyst who covers restaurants for the research group of asset manager William Blair. By raising awareness of the many different diets Chipotle is compatible with, it is "eliminating the veto factor," she said.Chipotle has come a long way since it suffered following an E. coli outbreak that 60 Chipotle customers in 14 states ill in late 2015 and early 2016.Now, customers are coming back. In 2018, the company reported a revenue increase of 8.7% compared to the previous year. Sales at restaurants open at least a year jumped 4% in that time frame, and digital sales surged 42.4%.To help drive the rebound, Chipotle unrolled its "for real" marketing campaign, which highlights ingredients and offers transparency into its operations, streamlined its pickup options, expanded its delivery services and made its production lines more efficient, among other things. 2897
An area tucked between peaks in the Rocky Mountains is home to a unique World War II training camp that may become the nation’s first National Historic Landscape. 174
An agency in Colorado that tracks avalanches hiked its danger level to "extreme" for a swath of the state, the highest level on its scale."Do not travel in the backcountry," the Colorado Avalanche Information Center said in a tweet Thursday. "Historic avalanches expected to valley floors."The extreme dangers are for Vail and Summit County, and the Sawatch, Gunnison and Aspen zones.Colorado has been with heavy snow and avalanches. Two deaths occurred there recently and an avalanche shut down a part of Interstate 70 and ruptured a natural gas pipeline.Spencer Logan, an avalanche forecaster with the Colorado Avalanche Information Center, said avalanches are "running bigger than the last 20 to 30 years" and in some cases bigger than the last 50 years. He expects avalanche dangers will be high through the weekend.He said the large amounts of snow that have fallen in short amounts of time have pushed slopes "closer and closer to the edge.""We're seeing more snow than we have for quite a few years."Logan said the forecasts are for areas outside town limits and the backcountry, and roads will be affected."Certainly these avalanches are having an impact on the highways," he said.The Colorado Department of Transportation will do what it can to reduce avalanche hazards and ski patrols will be on alert."Travel in, near, or below avalanche terrain is not recommended. Keep it simple and just AVOID the backcountry," the Friends of CAIC said on Twitter. 1473
A shark attack killed a 65-year-old man as he was swimming off the coast of Maui Saturday morning, according to authorities.The man, who was from California, encountered the shark about 60 yards off of Kaanapali Beach at around 8:30 a.m. local time, Dan Dennison, a spokesman for Hawaii's Department of Land and Natural Resources, told CNN.As a matter of protocol, authorities have posted signs along a half-mile stretch beach warning people of a shark, Dennison said.The man's identity has not been released. An incident report from the County of Maui Department of Fire and Public Safety -- obtained by 617
A pinch in the leg, a squeal and a trickle of tears. One baby after another in Malawi is getting the first and only vaccine against malaria, one of history’s deadliest and most stubborn of diseases.The southern African nation is rolling out the shots in an unusual pilot program along with Kenya and Ghana. Unlike established vaccines that offer near-complete protection, this new one is only about 40% effective. But experts say it’s worth a try as progress against malaria stalls: Resistance to treatment is growing and the global drop in cases has leveled off. With the vaccine, the hope is to help small children through the most dangerous period of their lives. Spread by mosquito bites, malaria kills more than 400,000 people every year, two-thirds of them under 5 and most in Africa.Seven-month-old Charity Nangware received a shot on a rainy December day at a health clinic in the town of Migowi. She watched curiously as the needle slid into her thigh, then twisted up her face with a howl.“I’m very excited about this,” said her mother, Esther Gonjani, who herself gets malaria’s aches, chills and fever at least once a year and loses a week of field work when one of her children is ill. “They explained it wasn’t perfect, but I feel secure it will relieve the pain.”There is little escaping malaria -- “malungo” in the local Chichewa language -- especially during the five-month rainy season. Stagnant puddles, where mosquitoes breed, surround the homes of brick and thatch and line the dirt roads through tea plantations or fields of maize and sugar cane. In the village of Tomali, the nearest health clinic is a two-hour bike ride away. The longer it takes to get care, the more dangerous malaria can be. Teams from the clinic offer basic medical care during visits once or twice a month, bringing the malaria shot and other vaccines in portable coolers. Treating malaria takes up a good portion of their time during the rainy season, according to Daisy Chikonde, a local health worker.“If this vaccine works, it will reduce the burden,” she said.Resident Doriga Ephrem proudly said her 5-month-old daughter, Grace, didn’t cry when she got the malaria shot.When she heard about the vaccine, Ephrem said her first thought was “protection is here.” Health workers explained, however, that the vaccine is not meant to replace antimalarial drugs or the insecticide-treated bed net she unfolds every night as the sun sets and mosquitoes rise from the shadows. “We even take our evening meals inside the net to avoid mosquitoes,” she said.It took three decades of research to develop the new vaccine, which works against the most common and deadly of the five parasite species that cause malaria. The parasite’s complex life cycle is a huge challenge. It changes forms in different stages of infection and is far harder to target than germs.“We don’t have any vaccines against parasites in routine use. This is uncharted territory,” said Ashley Birkett, who directs PATH’s Malaria Vaccine Initiative, a nonprofit that helped drugmaker GlaxoSmithKline develop the shot, brand-named Mosquirix. The bite of an infected mosquito sends immature parasites called sporozoites into the bloodstream. If they reach the liver, they’ll mature and multiply before spewing back into the blood to cause malaria’s debilitating symptoms. At that point, treatment requires medicines that kill the parasites.Mosquirix uses a piece of the parasite — a protein found only on sporozoites’ surface — in hopes of blocking the liver stage of infection. When a vaccinated child is bitten, the immune system should recognize the parasite and start making antibodies against it.Scientists also are searching for next-generation alternatives. In the pipeline is an experimental vaccine made of whole malaria parasites dissected from mosquitoes’ salivary glands but weakened so they won’t make people sick. Sanaria Inc. has been testing its vaccine in adults, and is planning a large, late-stage study in Equatorial Guinea’s Bioko Island.And the U.S. National Institutes of Health soon will start initial tests of whether injecting people periodically with lab-made antibodies, rather than depending on the immune system to make them, could offer temporary protection during malaria season. Think of them as “potentially short-term vaccines,” NIH’s Dr. Robert Seder told a recent meeting of the American Society of Tropical Medicine and Hygiene.For now, only babies in parts of Malawi, Kenya and Ghana are eligible for the Mosquirix vaccine. After the vaccine was approved in 2015, the World Health Organization said it first wanted a pilot roll-out to see how well it worked in a few countries — in real-world conditions — before recommending that the vaccine be given more widely across Africa. “Everyone is looking forward to getting it,” said Temwa Mzengeza, who oversees Malawi’s vaccine programs. Those eager for the shots include her husband, whom she had to stop from trying to get them, she said.Mzengeza used to come down with malaria several times a year until she started following her own advice to sleep under a net every night. Unlike many other kinds of infections, people can get malaria repeatedly, building up only a partial immunity.In the pilot program that began last year, 360,000 children in the three countries are meant to be vaccinated annually. The first dose is given at about age 5 months and the final, fourth booster near the child’s second birthday.Experts say it is too early to know how well the vaccine is working. They’re watching for malaria deaths, severe infections and cases of meningitis, something reported during studies but not definitively linked to the vaccine.“To do something completely new for malaria is exciting,” said researcher Don Mathanga, who is leading the evaluation in Malawi. The rainy season has brought new challenges, making some rural roads impassable and complicating efforts to track down children due for a shot. So far in Malawi, the first dose reached about half of the children targeted, about 35,000. That dropped to 26,000 for the second dose and 20,000 for the third. That’s not surprising for a new vaccine, Mzengeza said. “It will pick up with time.”At the health clinic in Migowi in Malawi’s southern highlands, workers see signs of hope. Henry Kadzuwa explains the vaccine to mothers waiting at the clinic. He said there was a drop in malaria cases to 40 in the first five months of the program, compared to 78 in the same period in 2018.Even though he wishes his 3-year-old daughter, Angel, could receive the vaccine, “it’s protecting my community. It also makes my work easier,” Kadzuwa said. The Migowi area has one of the country’s highest rates of malaria, and a worn paper register in the clinic’s laboratory lists scores of cases.At the clinic, Agnes Ngubale said she had malaria several years ago and wants to protect her 6-month-old daughter, Lydia, from the disease.“I want her to be healthy and free,” she said. “I want her to be a doctor.”And she has memorized the time for Lydia’s second dose: “Next month, same date.”___Neergaard reported from Washington.___The Associated Press Health and Science Department receives 7200